Skip to Content

4 Results Found

  • Article
  • Open Access
1 Citations
1,316 Views
26 Pages

A New GlyT2 Variant Associated with Hyperekplexia

  • Jorge Sarmiento-Jiménez,
  • Raquel Felipe,
  • Enrique Núñez,
  • Alejandro Ferrando-Muñoz,
  • Cristina Benito-Muñoz,
  • Federico Gago,
  • Jesús Vázquez,
  • Emilio Camafeita,
  • Emma Clement and
  • Beatriz López-Corcuera
  • + 1 author

Hyperekplexia (OMIM 149400), a sensorimotor syndrome of perinatal clinical relevance, causes newborns to display an energic startle reflex in response to certain trivial stimuli. This condition can be lethal due to apnea episodes. The disease is caus...

  • Article
  • Open Access
26 Citations
4,749 Views
15 Pages

Epilepsy and BRAF Mutations: Phenotypes, Natural History and Genotype-Phenotype Correlations

  • Domenica I. Battaglia,
  • Maria Luigia Gambardella,
  • Stefania Veltri,
  • Ilaria Contaldo,
  • Giovanni Chillemi,
  • Chiara Veredice,
  • Michela Quintiliani,
  • Chiara Leoni,
  • Roberta Onesimo and
  • Giuseppe Zampino
  • + 7 authors

26 August 2021

Objective: Cardiofaciocutaneous syndrome (CFCS) is a rare developmental disorder caused by upregulated signaling through the RAS-mitogen-activated protein kinase (MAPK) pathway, mostly resulting from de novo activating BRAF mutations. Children with C...

  • Review
  • Open Access
18 Citations
14,945 Views
15 Pages

10 September 2023

Stiff person spectrum disorders (SPSD) are paradigm autoimmune movement disorders characterized by stiffness, spasms and hyperekplexia. Though rare, SPSD represent a not-to-miss diagnosis because of the associated disease burden and treatment implica...

  • Feature Paper
  • Article
  • Open Access
7 Citations
3,603 Views
25 Pages

A System for Assessing Dual Action Modulators of Glycine Transporters and Glycine Receptors

  • Diba Sheipouri,
  • Casey I. Gallagher,
  • Susan Shimmon,
  • Tristan Rawling and
  • Robert J. Vandenberg

30 November 2020

Reduced inhibitory glycinergic neurotransmission is implicated in a number of neurological conditions such as neuropathic pain, schizophrenia, epilepsy and hyperekplexia. Restoring glycinergic signalling may be an effective method of treating these p...